1. |
Gemma L Carvill, Sinéad B Heavin, Simone C Yendle, et al. Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. Nature Genet, 2013, 45: 825-830.
|
2. |
Francesca Novara, Ambra Rizzo, Gloria Bedini, et al. MEF2C deletions and mutations versus duplications: a clinical comparison. Eur J Hum Genet, 2013, 56(5): 260-265.
|
3. |
Keiko Shimojima, Akihisa Okumura, Harushi Mori, et al. De novo mierodeletion of 5q14.3 excluding MEF2C in a patient with infantile spasms, microcephaly, and agenesis of the corpus allosum. Am J Genet A, 2012, 158A(9): 2272-2276.
|
4. |
Irena Vrečar, Josie Innes, Elizabeth A Jones, et al. Further clinical delineation of the MEF2C haploinsufficiency syndrome: report on new cases and literature review of severe neurodevelopmental disorders presenting with seizures, absent speech, and involuntary movements. J Pediatr Genet, 2017, 6: 129-141.
|
5. |
Novara F, Beri S, Giorda R, et al. Refining the phenotype associated with MEF2C haploinsufficiency. Clin Genet, 2010, 78(5): 471-477.
|
6. |
Nowakowska BA, Obersztyn E, Szymańska K, et al. Severe mental retardation, seizures, and hypotonia due to deletions of MEF2C. Am J Med Genet B Neuropsychiatr Genet, 2010, 153B(5): 1042-1051.
|
7. |
Le Meur N, Holder-Espinasse M, Jaillard S, et al. MEF2C haploin-sufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations. J Med Genet, 2010, 47(1): 22-29.
|
8. |
俞冬熠, 李朔, 姜楠. 5q14.3微缺失综合征导致婴儿痉挛症一家系的临床及遗传学研究. 中华儿科杂志, 2015, 53(2): 140-142.
|
9. |
Tanteles GA, Alexandrou A, Evangelidou P, et al. Partial MEF2C deletion in a Cypriot patient with severe intellectual disability and a jugular fossa malformation: review of the literature. Am J Med Genet A, 2015, 167A(3): 664-669.
|
10. |
Zweier M, Rauch A. The MEF2C-related and 5q14.3q15 micro-deletion syndrome. Mol Syndromol, 2012, 2(3-5): 164-170.
|
11. |
Rocha H, Sampaio M, Rocha R, et al. MEF2C haploinsufficiency syndrome: report of a new MEF2C mutation and review. Eur J Med Genet, 2016, 59(9): 478-482.
|
12. |
Paciorkowski AR, Traylor RN, Rosenfeld JA, et al. MEF2C haploin-sufficiency features consistent hyperkinesis, variable epilepsy, and has a role in dorsal and ventral neuronal developmental pathways. Neurogenetics, 2013, 14(2): 99-111.
|